Proteomics: New Developments in Target Discovery.
The Society for Medicines Research in collaboration with the Biological and Medicinal Chemistry sector of the Royal Society for Chemistry held a meeting on September 19, 2002, in London, United Kingdom to discuss proteomics in drug discovery. The meeting gave the most up-to-date overview of current progress in this new field, the challenges in silico, in vitro and in vivo, together with consideration of the increasing contribution of bioanalysis, bioinformatics and pharmacogenomics. Speakers from Celera Genomics, Oxford GlycoSciences and GlaxoSmithKline, among other companies and institutions, were present. (c) 2002 Prous Science. All rights reserved.
Journal Article↗